Pure Global AI
MCA MCA-F-501

MCA-F-501/07, version 2 – 24 February 2025

Clinical Trial Progress Report
GambiaMedicines Control Agency, The GambiaClinical TrialsCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MCA-F-501/07, version 2 – 24 February 2025 is the official MCA identifier for “Clinical Trial Progress Report”. MCA-F-501/07, version 2 – 24 February 2025 is the official identifier MCA uses for this instrument.

Instrument
MCA-F-501
Full name
MCA-F-501/07, version 2 – 24 February 2025
Category
Clinical Trials
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Clinical Trial Progress Report

Complete four-page clinical trial progress report, version 2 dated 24 February 2025. It records study and site progress, participants, adverse events, trial changes, amendments and protocol or GCP deviations. It states that added trial sites should be submitted as an amendment and contains a conditional ethics-opinion review note; neither is a general device marketing variation rule or market-processing deadline. Both printed SECTION G headings are retained. Later revisions and current applicability remain unverified.

MCA-F-501/07, version 2 – 24 February 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.